Total laparoscopic radical hysterectomy for treatment of uterine malignant tumors: analysis of short-term therapeutic efficacy
- PMID: 20556585
- DOI: 10.1007/s11596-010-0360-5
Total laparoscopic radical hysterectomy for treatment of uterine malignant tumors: analysis of short-term therapeutic efficacy
Abstract
To investigate the efficacy and the clinical value of total laparoscopic radical hysterectomy (TLRH) for the treatment of uterine malignancies, we performed a retrospective review of 87 patients with cervical cancer and 23 patients with endometrial carcinoma who underwent TLRH at Union hospital between June 2008 and September 2009. Data collected included operative time, estimated blood loss, lymph node count, time for the recovery of normal temperature and time to resumption of normal bladder function, intraoperative and postoperative complications. The procedure was completed laparoscopically in 108 patients. Two patients were converted to laparotomy due to common iliac vein injury. The mean overall operative time was 200.6+/-38.6 min; the mean operative blood loss was 280.5+/-128.3 mL; he mean number of pelvic lymph nodes that were resected wa26. 0+/-5.8. The time for recovery of normal temperature and the normal bladder function after the operation was 5.8+/-2.9 d and 15.2+/-4.3 d. There were 2 (1.8%) common iliac vein injuries during the operation and 10 (9.1%) bladder retentions post operation. It was concluded that TLRH is feasible, minimally invasive and provides promise for the treatment of uterine malignancies.
Similar articles
-
Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience.Gynecol Oncol. 2006 Aug;102(2):252-5. doi: 10.1016/j.ygyno.2005.12.013. Epub 2006 Feb 10. Gynecol Oncol. 2006. PMID: 16472844
-
Standardized technique of laparoscopic pelvic and para-aortic lymphadenectomy in gynecologic cancer optimizes the perioperative outcomes.Arch Gynecol Obstet. 2011 Jun;283(6):1373-80. doi: 10.1007/s00404-010-1580-4. Epub 2010 Jul 6. Arch Gynecol Obstet. 2011. PMID: 20607263
-
Feasibility and morbidity of total laparoscopic radical hysterectomy with or without pelvic limphadenectomy in obese women with stage I endometrial cancer.Arch Gynecol Obstet. 2009 May;279(5):655-60. doi: 10.1007/s00404-008-0790-5. Epub 2008 Sep 16. Arch Gynecol Obstet. 2009. PMID: 18795308 Clinical Trial.
-
The value of laparoscopic surgery to stage gynecological cancers: present and future.Minerva Ginecol. 2009 Aug;61(4):319-37. Minerva Ginecol. 2009. PMID: 19745797 Review.
-
Robotic radical hysterectomy. A literature review.Minerva Ginecol. 2009 Aug;61(4):339-46. Minerva Ginecol. 2009. PMID: 19745798 Review.
Cited by
-
Treatment of early bulky cervical cancer with neoadjuvant paclitaxel, carboplatin and cisplatin prior to laparoscopical radical hysterectomy and pelvic lymphadenectomy.Oncol Lett. 2012 Mar;3(3):641-645. doi: 10.3892/ol.2011.529. Epub 2011 Dec 19. Oncol Lett. 2012. PMID: 22740967 Free PMC article.
-
Laparoscopic procedure compared with open radical hysterectomy with pelvic lymphadenectomy in early cervical cancer: a retrospective study.Onco Targets Ther. 2018 Sep 18;11:5903-5908. doi: 10.2147/OTT.S156064. eCollection 2018. Onco Targets Ther. 2018. PMID: 30271174 Free PMC article.
-
Perioperative and long-term outcomes of laparoscopy and laparotomy for endometrial carcinoma.Int J Clin Exp Med. 2015 Oct 15;8(10):19093-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770538 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical